 |
|
|
| |
Two Years of Truvada for Pre-Exposure Prophylaxis
Utilization in the United States
|
| |
| |
Reported by Jules Levin
HIV Drug Therapy
November 2-6, 2014
Glasgow, UK
C Flash1, R Landovitz2, R Mera-Giler3, L Ng3, D Magnuson3, S Bush-Wooley4, K Rawlings4
1Baylor College of Medicine, Medicine, Section of Infectious Diseases, Houston, United States;
2David Geffen School of Medicine, Medicine, Division of Infectious Diseases, Los Angeles, United States;
3Gilead Sciences, Drug Safety & Public Health, Foster City, United States;
4Gilead Sciences, Medical Affairs, Foster City, United States
|
| |
|
|
|
|
|
